Brand Logo

Treatment

Product
FAVIPIRAVIR
Our partnership with Japan's Fujifilm Toyama Chemical, innovators of Favipiravir, will enable us to make the product accessible to COVID-19 patients around the world. Favipiravir is an oral antiviral drug that works by inhibiting the multiplication of the infection-causing virus, thus decreasing the viral load in the body.
Product
REMDESIVIR
We have partnered with US company Gilead Sciences, innovators of Remdesivir, to make the product available for COVID-19 patients globally. Remdesivir is an injectable antiviral drug that stops the multiplication of the infection-causing virus, thereby decreasing the body's viral load.
Product
MOLNUPIRAVIR
We have collaborated with American company Merck & Co, innovators of Molnupiravir, to make the product accessible to COVID-19 patients around the world. Molnupiravir is an investigational oral antiviral drug that inhibits the multiplication of the infection-causing virus, thereby decreasing the viral load in the body. It is currently undergoing Phase 3 clinical studies globally for treating mild to moderate COVID-19.
Product
2-DG
In collaboration with India's Defence Research and Development Organisation, we are producing 2-deoxy-D-glucose or 2-DG to treat COVID-19. It is an oral antiviral and anti-inflammatory drug that inhibits viral multiplication and decreases inflammation in the body.
Product
BARICITINIB
Our partnership with the US-based Eli Lilly and Company, innovators of Baricitinib, will enable us to bring the product to India. Baricitinib is an oral drug that reduces the body's unwanted inflammatory response to COVID-19. It also prevents the entry of the virus causing the disease into cells.
Product
2-DG
In collaboration with India's Defence Research and Development Organisation, we are producing 2-deoxy-D-glucose or 2-DG to treat COVID-19. It is an oral antiviral and anti-inflammatory drug that inhibits viral multiplication and decreases inflammation in the body.
Product
REMDESIVIR
We have partnered with US company Gilead Sciences, innovators of Remdesivir, to make the product available for COVID-19 patients globally. Remdesivir is an injectable antiviral drug that stops the multiplication of the infection-causing virus, thereby decreasing the body's viral load.
Product
BARICITINIB
Our partnership with the US-based Eli Lilly and Company, innovators of Baricitinib, will enable us to bring the product to India. Baricitinib is an oral drug that reduces the body's unwanted inflammatory response to COVID-19. It also prevents the entry of the virus causing the disease into cells.
*These products are not for the US market.

Click on any stage of the COVID treatment journey to see our product offerings

Treatment

*These products are not for the US market.